Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anaphylactic Shock
Recent studies from Southampton University add new data to anaphylactic shock
December 17th, 2008
"Anaphylaxis as an adverse event following immunisation (AEFI) is a rare occurrence. We report four cases of anaphylaxis following administration of single component measles or rubella vaccine between January 2003 and June 2007," scientists in Southampton, the United Kingdom report. "We estimate that the incidence of anaphylaxis to measles and rubella single component vaccines is 18.9 and 22.4 cases/100 000 doses, respectively. These figures are likely to be an underestimate but are higher than expected. Our calculations were hampered by lack of immunisation reporting data from the private sector," wrote M. Erlewynlajeunesse and colleagues, Southampton...
Source: Vaccine Weekly (2008-12-17)
|
